PW
Research Associate
MV
Biology Technician
Get the full picture
Sign in to uncover key details.
Afraxis
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6605 Nancy Ridge Dr Ste 224, San Diego, ...Phone Number
(858) 436-1539Website
www.afraxis.comRevenue
<$5 MillionIndustry
About Afraxis
Afraxis Inc. develops high-content CNS pharmaceutical screening technologies to evaluate pre-clinical therapeutics for the treatment of neurological and psychiatric disorders. Afraxis developed the emergent technology Afraxis ESP (Enhanced Spine Analysis Platform), which quantifies the morphology and maturity of synaptic dendritic spines which are fundamental to information processing by neural synapses in the brain. Afraxis is part of a growing wave of innovative Neuroscience that applies cutting-edge technical and computational approaches to fundamental issues in brain science that promise to generate new insights into CNS diseases. Afraxis Inc. is a San Diego-based spin-out company co-founded by Afraxis Holdings, Christopher Rex and Carmine Stengone in April 2013.Explore more
Afraxis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Afraxis
Compare insights from companies similar to Afraxis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Afraxis Tech Stack
A closer look at the technologies used by Afraxis
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Afraxis
Sign Up For FreeTo access detailed company insights
Afraxis Inc. develops high-content CNS pharmaceutical screening technologies to evaluate pre-clinical therapeutics for the treatment of neurological and psychiatric disorders. Afraxis developed the emergent technology Afraxis ESP (Enhanced Spine Analysis Platform), which quantifies the morphology and maturity of synaptic dendritic spines which are... Read More
